Seropositivity and reactivations of HSV-1, but not of HSV-2 nor VZV, associate with altered blood-brain barrier, beta amyloid, and tau proteins in people living with HIV

J Neurovirol. 2023 Feb;29(1):100-105. doi: 10.1007/s13365-022-01105-z. Epub 2022 Nov 9.

Abstract

Among 128 adult people living with HIV and no neurological conditions confounding the cerebrospinal fluid results, the presence of HSV-1 chronic infection (detected either by serology or PCR), but not of HSV-2 and VZV, independently associated with higher odds of blood-brain barrier impairment, abnormally increased cerebrospinal fluid levels of tau and phosphorylated-181 tau, and decreased concentrations of fragments 1-42 of beta amyloid compared to the seronegative counterpart. These associations were even stronger for seropositive participants with a positive history of at least one symptomatic reactivation of HSV-1.

Keywords: Alzheimer’s dementia; Blood–brain barrier; Cerebrospinal fluid biomarkers; HIV; Herpes simplex; Varicella zoster.

MeSH terms

  • Adult
  • Amyloid beta-Peptides / cerebrospinal fluid
  • Blood-Brain Barrier
  • HIV Infections* / cerebrospinal fluid
  • Herpesvirus 1, Human* / physiology
  • Herpesvirus 2, Human
  • Humans
  • tau Proteins / cerebrospinal fluid

Substances

  • Amyloid beta-Peptides
  • tau Proteins